Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2007-03-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00262-007-0312-5PMID 17387473PMCID PMC11030741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-Infiltrating Cytotoxic T Cells but not Regulatory T Cells Predict Outcome in Anal Squamous Cell Carcinoma

  2006cited by this paper
• A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

  2006cited by this paper
• High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

  2006cited by this paper
• Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients

  2006cited by this paper
• FOXP3+CD4+CD25+ Adaptive Regulatory T Cells Express Cyclooxygenase-2 and Suppress Effector T Cells by a Prostaglandin E2-Dependent Mechanism1

  2006cited by this paper
• Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells1

  2005cited by this paper
• Role of cyclooxygenase‐2 in immunomodulation and prognosis of endometrial carcinoma

  2005cited by this paper
• Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.

  2005cited by this paper
• Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.

  2005cited by this paper
• The promise of cancer vaccines

  2004cited by this paper
• Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.

  2003cited by this paper
• Tumor-Associated Macrophages and Dendritic Cells as Prototypic Type II Polarized Myeloid Populations

  2003cited by this paper
• Cyclooxygenase-2 Inhibition Improves Macrophage Function in Melanoma and Increases the Antineoplastic Activity of Interferon γ

  2003cited by this paper
• Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.

  2003cited by this paper
• Impaired monocyte function in cancer patients: restoration with a cyclooxygenase‐2 inhibitor

  2003cited by this paper
• Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population.

  2002cited by this paper
• Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response.

  2002cited by this paper
• Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.

  2001cited by this paper
• Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer.

  2001cited by this paper
• T-helper (Th)1/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma

  2001cited by this paper
• Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

  2001cited by this paper
• The coxibs, selective inhibitors of cyclooxygenase-2.

  2001cited by this paper
• Role of BAX in the apoptotic response to anticancer agents.

  2000cited by this paper
• Tumor cell‐derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac‐1

  2000cited by this paper
• 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.

  2000cited by this paper
• Defective Expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in Macrophages Associated with Human Ovarian Carcinoma1

  2000cited by this paper
• Serum interleukin-10 is an independent prognostic factor in advanced solid tumors.

  2000cited by this paper
• Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis1

  2000cited by this paper
• Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells.

  2000cited by this paper
• Sulindac inhibits activation of the NF-kappaB pathway.

  1999cited by this paper
• Sulindac Inhibits Activation of the NF-κB Pathway*

  1999cited by this paper
• British Journal of Cancer

  1999cited by this paper
• Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

  1998cited by this paper
• Th1 and Th2 Cytokine Response Patterns in Leukocyte Cultures of Patients with Urinary Bladder, Renal Cell and Prostate Carcinomas

  1998cited by this paper
• CCR5 is characteristic of Th1 lymphocytes

  1998cited by this paper
• Tumor‐induced immune dysfunction: the macrophage connection

  1998cited by this paper
• Integrin affinity modulation.

  1998cited by this paper
• Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer

  1997cited by this paper
• Study of tumor infiltrating lymphocytes and transforming growth factor‐β as prognostic factors in breast carcinoma

  1997cited by this paper
• Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation

  1996cited by this paper
• Identification of a major co-receptor for primary isolates of HIV-1

  1996cited by this paper
• Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.

  1996cited by this paper
• Involvement of leukocyte (β2) integrins (CD18/CD11) in human monocyte tumoricidal activity

  1991cited by this paper
• Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis.

  1991cited by this paper
• Regulation of the immune response by prostaglandins

  1983cited by this paper

• Lipid metabolic rewiring in glioma-associated microglia/macrophages (Review)

  2024cites this paper
• Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy

  2023cites this paper
• Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Combination of β2-AR Blocker and COX-2 Inhibitor Suppresses Development of Oral Squamous Cell Carcinoma

  2020cites this paper
• Repurposing of Drugs for Immunotherapy

  2018cites this paper
• COX-2 inhibitor prevents tumor induced down regulation of classical DC lineage specific transcription factor Zbtb46 resulting in immunocompetent DC and decreased tumor burden.

  2017cites this paper
• Head and Neck Carcinoma Immunotherapy: Facts and Hopes

  2017cites this paper
• Cyclooxygenase Inhibition in Cancer Immunotherapy: Combination of Indomethacin with Cancer Vaccines Is Not Always Beneficial

  2017cites this paper
• Introducing Cytology-Based Theranostics in Oral Squamous Cell Carcinoma: A Pilot Program

  2016cites this paper
• COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages

  2016cites this paper
• Consistent Inhibition of Cyclooxygenase Drives Macrophages towards the Inflammatory Phenotype

  2015cites this paper
• Effect of nimesulide on the growth of human laryngeal squamous cell carcinoma.

  2014cites this paper
• Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

  2013cites this paper
• New drugs for head and neck cancer

  2012cites this paper
• Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy.

  2012cites this paper
• [Analysis of HIF-1α and COX-2 expression in tumor stroma and correlation with the degree of neoplasm invasiveness in laryngeal cancer--preliminary study].

  2011cites this paper
• Cyclooxygenase-2 expression in oral tongue squamous cell carcinoma.

  2011cites this paper
• Analiza ekspresji HIF-1α i COX-2 w utkaniu guza oraz korelacja ze stopniem inwazyjności zmian nowotworowych u chorych z rakiem krtani – badania wstępne

  2011cites this paper
• Control of Disease Recurrence by Tumor-Infiltrating T Cells in Ovarian Cancer

  2010cites this paper
• Immunohistochemical detection of Ki-67 is not associated with tumor-infiltrating macrophages and cyclooxygenase-2 in oral squamous cell carcinoma.

  2010cites this paper
• Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression

  2009cites this paper
• The Immune System and Cancer

  2009influential citation
• Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

  2009cites this paper
• [Head and neck squamous cell carcinoma: What's new in 2009].

  2009cites this paper
• Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion

  2008cites this paper
• Editorial comment on: celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma.

  2008cites this paper
• Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma.

  2008cites this paper
• Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.

  2007cites this paper